Low T IS a detriment to CV health. Low T (and E2) may be why my Lp(a) (a marker for atherogenesis) has risen lately.
The problem with these studies I posted are that they are one-sided and don't always take into account many other epigenetic factors that influence gene expression, etc. I think T is a modulator of pretty much all functions. In other words, you take too much, your risk of adverse events increases, you have too little, same thing. Dose dependent.
Hopefully Nelson will chime in here.
